RECOVER-ENERGIZE Platform Protocol

NCT ID: NCT06404047

The RECOVER-ENERGIZE trial is studying different ways to help people who have long-lasting symptoms after recovering from COVID-19, known as Long COVID. Many individuals experience problems like ex...

Recruiting

Phase: NA Conditions: Long COVID, Long Covid19 +1 more

RECOVER-SLEEP: Platform Protocol

NCT ID: NCT06404086

The RECOVER-SLEEP trial is a research study that aims to find out how different treatments can help people who are experiencing sleep problems after having COVID-19, also known as Long COVID. Speci...

Recruiting

Phase: PHASE2 Conditions: Sleep Disturbance, Long COVID +2 more

MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles

NCT ID: NCT03053193

The FLEX Registry is a clinical trial aimed at studying how specific gene tests, called MammaPrint® and BluePrint, can help doctors understand breast cancer better. This trial is for patients with ...

Recruiting

Conditions: Breast Cancer

Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma

NCT ID: NCT03937635

This clinical trial is studying how effective a combination of three medications—lenalidomide, dexamethasone, and daratumumab—are in treating patients with high-risk smoldering myeloma. Smoldering ...

Recruiting

Phase: PHASE3 Conditions: Smoldering Plasma Cell Myeloma

Pimavanserin vs. Quetiapine for Treatment of Parkinson's Psychosis

NCT ID: NCT04373317

This clinical trial is studying two medications, Pimavanserin and Quetiapine, to see which one works better for treating psychosis in veterans with Parkinson's disease. Psychosis can cause troublin...

Recruiting

Phase: PHASE4 Conditions: Parkinson's Disease Psychosis

Using Biomarkers to Help Guide Safe Immunotherapy Discontinuation in Patients With Unresectable Stage IIIB-IV Melanoma, The PET-Stop Trial

NCT ID: NCT04462406

The PET-Stop Trial is a study looking at how doctors can use special tests called biomarkers from PET/CT scans to decide if patients with advanced melanoma can safely stop their anti-PD-1 treatment...

Recruiting

Phase: PHASE2 Conditions: Advanced Melanoma, Unresectable Melanoma +9 more

Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial

NCT ID: NCT04566328

The EQUATE Trial is a research study looking at how effective a combination of four cancer-fighting drugs is for adults who have just been diagnosed with multiple myeloma, a type of blood cancer. T...

Recruiting

Phase: PHASE3 Conditions: Plasma Cell Myeloma, RISS Stage II Plasma Cell Myeloma +1 more

A Study of Guselkumab Administered Subcutaneously in Bio-naive Participants With Active Psoriatic Arthritis Axial Disease

NCT ID: NCT04929210

This clinical trial is studying a medication called guselkumab to see how well it works for people with active psoriatic arthritis (PsA) that affects the spine and pelvis. The goal is to find out i...

Recruiting

Phase: PHASE4 Conditions: Arthritis, Psoriatic

Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis

NCT ID: NCT05047172

This clinical trial is looking to compare different blood-thinning medications to see which is most effective in preventing strokes and other serious issues related to narrowed blood vessels in the...

Recruiting

Phase: PHASE3 Conditions: Stroke, Intracranial Arteriosclerosis

Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)

NCT ID: NCT05281471

The OnPrime study is a clinical trial that is investigating a new treatment approach for women with certain types of ovarian cancer that have not responded well to standard chemotherapy, known as p...

Recruiting

Phase: PHASE3 Conditions: Fallopian Tube Cancer, Primary Peritoneal Cancer +5 more

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

NCT ID: NCT05579366

This clinical trial is investigating a new drug called PRO1184 for patients with various types of advanced solid tumors, including different forms of ovarian, lung, and breast cancer. The main goal...

Recruiting

Phase: PHASE1 Conditions: Non-small Cell Lung Cancer, Endometrial Cancer +13 more

A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE

NCT ID: NCT05702034

The LIBREXIA-STROKE trial is studying a new medication called milvexian to see if it can help prevent another ischemic stroke in people who have recently experienced one or a high-risk transient is...

Recruiting

Phase: PHASE3 Conditions: Ischemic Stroke; Ischemic Attack, Transient

A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome

NCT ID: NCT05754957

This clinical trial is studying a medication called milvexian to see if it can help reduce the risk of serious heart problems in patients who have recently experienced an acute coronary syndrome (A...

Recruiting

Phase: PHASE3 Conditions: Acute Coronary Syndrome

A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy

NCT ID: NCT05889182

This clinical trial is studying a medication called upadacitinib to see how effective and safe it is for treating moderate to severe hidradenitis suppurativa (HS) in adults and adolescents who have...

Recruiting

Phase: PHASE3 Conditions: Hidradenitis Suppurativa

LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF

NCT ID: NCT05983250

The LEVosimendan trial is studying a new oral medication called TNX-103 to see if it can help patients with pulmonary hypertension and heart failure with preserved ejection fraction (PH-HFpEF) impr...

Recruiting

Phase: PHASE3 Conditions: Pulmonary Hypertension

Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study

NCT ID: NCT05987241

The MODERN study is a clinical trial designed to explore how a blood test can help identify bladder cancer patients who may need additional treatment after having their bladder surgically removed. ...

Recruiting

Phase: PHASE2 Conditions: Stage III Bladder Urothelial Carcinoma AJCC v6 and v7, Stage IV Bladder Urothelial Carcinoma AJCC v7 +5 more

A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

NCT ID: NCT06635148

This clinical trial is studying the long-term safety and tolerability of a treatment called JNJ-81201887 for people with Geographic Atrophy (GA), a condition related to Age-related Macular Degenera...

Recruiting

Phase: PHASE2 Conditions: Macular Degeneration, Geographic Atrophy

Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery

NCT ID: NCT02734537

This clinical trial is exploring the effectiveness of radiation therapy, with or without the chemotherapy drug cisplatin, for patients who have stage III or IVA squamous cell carcinoma of the head ...

Recruiting

Phase: PHASE2 Conditions: Head and Neck Squamous Cell Carcinoma, Stage III Laryngeal Cancer AJCC v8 +14 more

Pan Tumor Rollover Study

NCT ID: NCT03899155

The Pan Tumor Rollover Study is a clinical trial focused on understanding the long-term safety of a cancer treatment called nivolumab, both on its own and in combination with other therapies. This ...

Recruiting

Phase: PHASE2 Conditions: Cancer

The ENCIRCLE Trial

NCT ID: NCT04153292

The ENCIRCLE Trial is a study looking at the safety and effectiveness of a device called the SAPIEN M3 System for patients who have a serious heart condition known as mitral regurgitation (MR), whi...

Recruiting

Phase: NA Conditions: Mitral Regurgitation, Mitral Valve Insufficiency

Main Menu

Clinical Trials in Tucson, Arizona

578 Active Trials Found in Tucson

RECOVER-ENERGIZE Platform Protocol

RECOVER-SLEEP: Platform Protocol

MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles

Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma

Pimavanserin vs. Quetiapine for Treatment of Parkinson's Psychosis

Using Biomarkers to Help Guide Safe Immunotherapy Discontinuation in Patients With Unresectable Stage IIIB-IV Melanoma, The PET-Stop Trial

Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial

A Study of Guselkumab Administered Subcutaneously in Bio-naive Participants With Active Psoriatic Arthritis Axial Disease

Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis

Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE

A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome

A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy

LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF

Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study

A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery

Pan Tumor Rollover Study

The ENCIRCLE Trial